# US 2004/0082027 A1 · Conjugate of a tissue non-specific alkaline phosphatase and dextran, process for its production and use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0082027 A1
- Document ID: US20040082027A1
- Status: Published application
- Kind: A1
- Application number: 10/624,154
- Filed: 2003-07-21
- Published: 2004-04-29
- Earliest claimed: 2002-07-22
- Assignees: Roche Diagnostics Operations, Inc.
- Inventors: Bernd Schneidinger; Thomas Meier; Rainer Schmuck; Zhixin Shao
- Web page: https://patentgrep.com/patent/US20040082027A1

## CPC

- G01N 33/96: involving blood or serum control standard
- C12N 9/14: Hydrolases (3)
- C12Q 1/42: involving phosphatase
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

A conjugate of a tissue non-specific alkaline phosphatase (tns-AP) and dextran which can be obtained by reacting unglycosylated tns-AP with activated dextran by incubation in aqueous solution, stopping the reaction and isolating the conjugate from the solution. The conjugate obtained in this manner is suitable as a standard for the determination of alkaline phosphatase.

## Claims

### Claim 1

Conjugate of a tissue non-specific alkaline phosphatase (tns-AP) and dextran obtainable by reacting unglycosylated tns-AP with activated dextran in aqueous solution, stopping the reaction and isolating the conjugate from the solution.

### Claim 2 (depends on 1)

Conjugate as claimed in claim 1, characterized in that a tns-AP is used as the unglycosylated tns-AP which has been obtained by recombinant expression of a nucleic acid coding for tns-AP in a prokaryotic cell.

### Claim 3 (depends on 1, 2)

Conjugate as claimed in claim 1 or 2, characterized in that a dextran having an average molecular weight of 10-500 kDa is used.

### Claim 4

Process for producing a conjugate by reacting unglycosylated tns-AP with activated dextran by incubation in an aqueous solution, stopping the reaction and isolating the conjugate from the solution.

### Claim 5 (depends on 4)

Process for producing a conjugate as claimed in claim 4, characterized in that a tns-AP is used as the unglycosylated tns-AP which has been obtained by recombinant expression of a nucleic acid coding for tns-AP in a prokaryotic cell.

### Claim 6 (depends on 4, 5)

Process for producing a conjugate as claimed in claim 4 or 5, characterized in that a dextran having an average molecular weight of 10-500 kDa is used.

### Claim 7 (depends on 4, 5, 6)

Process for producing a conjugate as claimed in claims 4 to 6, characterized in that the dextran is activated with CDAP or CNBr.

### Claim 8 (depends on 4, 5, 6, 7)

Process for producing a conjugate as claimed in claims 4 to 7, characterized in that unglycosylated tns-AP and activated dextran are used for the said reaction in a ratio of 1:2 to 1:500.

### Claim 9 (depends on 1, 2, 3)

Use of a conjugate as claimed in claims 1-3 as standard in a method for the quantitative determination of alkaline phosphatase.

### Claim 10

Use of an unglycosylated tns-AP to produce a conjugate of unglycosylated tns-AP and dextran.
